
SEC registered adviser
Catalio Capital Management
New York-based healthcare investment manager covering private equity and venture, structured credit, public equities and co-investments in innovative life sciences companies, supported by a network of scientist-entrepreneur Venture Partners.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Catalio Capital Management right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Catalio Capital Management joined, from press and the firm’s own posts.
5 rounds in the last 12 months
Round sizes, Catalio Capital Management’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Catalio Capital Management backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Catalio Capital Management
Events where Catalio Capital Management’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Catalio Capital Management is based in New York, United States. It also has offices in New York City, Washington DC and London.
23 fund vehicles are on public registers (SEC adviser filings), including CATALIO NEXUS FUND IV, LP, CATALIO NEXUS FUND III, LP and CATALIO PUBLIC EQUITIES MASTER FUND, LP.
Sectors: Life sciences, Medtech. From the firm’s own website.
Catalio backs life sciences companies building drugs, devices, diagnostics, data and tools, and healthcare services, from inception through exit and across the capital structure. It leans on a network of renowned scientist-entrepreneurs for deal flow and scientific diligence, and favors strong IP and experienced management. From the firm’s own website.
Catalio Capital Management lists 100 portfolio companies on its website, including 9amHealth, Abridge, AdvanCell, Alentis Therapeutics and Amalgam Rx.
Firms whose websites list some of the same companies include RA Capital, 5AM Ventures and Agent Capital.
Know before Catalio Capital Management’s next round is announced.
PRO tracks Catalio Capital Management’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.